Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Radiofrequency Ablation (RFA)
    • 1.2.1.2 Radiation Therapy
    • 1.2.1.3 Chemotherapy
    • 1.2.1.4 Targeted Therapies
    • 1.2.1.5 Immunotherapy
  • 1.2.2 by Application
    • 1.2.2.1 Hospital
    • 1.2.2.2 Clinic
    • 1.2.2.3 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Radiofrequency Ablation (RFA) Market, 2013-2018
  • 4.1.2 Radiation Therapy Market, 2013-2018
  • 4.1.3 Chemotherapy Market, 2013-2018
  • 4.1.4 Targeted Therapies Market, 2013-2018
  • 4.1.5 Immunotherapy Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Radiofrequency Ablation (RFA) Market Forecast, 2019-2024
  • 4.2.2 Radiation Therapy Market Forecast, 2019-2024
  • 4.2.3 Chemotherapy Market Forecast, 2019-2024
  • 4.2.4 Targeted Therapies Market Forecast, 2019-2024
  • 4.2.5 Immunotherapy Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Hospital Market, 2013-2018
  • 5.1.2 Clinic Market, 2013-2018
  • 5.1.3 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Hospital Market Forecast, 2019-2024
  • 5.2.2 Clinic Market Forecast, 2019-2024
  • 5.2.3 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Bristol-Myers Squibb
• 8.2 GlaxoSmithKline
• 8.3 Menarini
• 8.4 Sanofi
• 8.5 Ziopharm Oncology
• 8.6 Alchemia
• 8.7 Amgen
• 8.8 Apotex
• 8.9 BioMarin Pharmaceutical
• 8.10 CellAct Pharma
• 8.11 Cerulean Pharma
• 8.12 Cipla
• 8.13 Cornerstone Pharmaceuticals
• 8.14 Curis
• 8.15 CytRx
• 8.16 Eli Lilly
• 8.17 Exelixis
• 8.18 Fresenius Kabi
• 8.19 Genentech
• 8.20 Hikma Pharmaceuticals
• 8.21 Hospira
• 8.22 Intas Pharmaceuticals
• 8.23 Karyopharm Therapeutics
• 8.24 Kyowa Hakko Kirin
• 8.25 Ligand Pharmaceuticals

9 Conclusion

Summary
The global Drugs for Non-small Cell Lung Cancer market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Radiofrequency Ablation (RFA) 
Radiation Therapy 
Chemotherapy 
Targeted Therapies 
Immunotherapy
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bristol-Myers Squibb 
GlaxoSmithKline 
Menarini 
Sanofi 
Ziopharm Oncology 
Alchemia 
Amgen 
Apotex 
BioMarin Pharmaceutical 
CellAct Pharma 
Cerulean Pharma 
Cipla 
Cornerstone Pharmaceuticals 
Curis 
CytRx 
Eli Lilly 
Exelixis 
Fresenius Kabi 
Genentech 
Hikma Pharmaceuticals 
Hospira 
Intas Pharmaceuticals 
Karyopharm Therapeutics 
Kyowa Hakko Kirin 
Ligand Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital 
Clinic 
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa